Hanmi Pharm acquires world’s first approval of combination drug for treatment of both asthma and allergic rhinitis

Hanmi Pharm(CEO Jong-Soo Woo, Sae-Chang Kown) announced on the 17^th that it acquired commercialization approval of ‘Monterizine,’ a combination drug for patients with both asthma and allergic rhinitis(allergic rhinitis symptom relief), from the Ministry of Food and Drug Safety(MFDS).

Monterizine, a product combining Montelukast 10mg, a substance that relieve asthma and rhinitis symptoms by inh...